Finanzwire Finanzwire
Basculer en Français
10336 Companies
214530 Keywords
144356 Articles
113632 Press releases
Headlines Articles Press releases Norgine Remove
  1. Home
  2. Companies
  3. Norgine
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/26/2026 at 07:10, 1 month 6 days ago

    Swissmedic Approves PEDMARQSI® for Preventing Hearing Loss in Children

    Swissmedic Approval Norgine PEDMARQSI® Children's Hearing Loss Cisplatin Chemotherapy
  • PRESS RELEASE

    published on 03/26/2026 at 07:05, 1 month 6 days ago

    Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children

    Norgine announces Swissmedic approval of PEDMARQSI(R) for the prevention of cisplatin induced hearing loss in children. PEDMARQSI(R) becomes the first treatment in Switzerland for this medical need
    Children Swissmedic Approval Norgine PEDMARQSI Cisplatin Induced Hearing Loss
    Logo of Norgine
  • BRIEF

    published on 02/27/2026 at 13:10, 2 months 2 days ago

    Norgine Awaits European Commission's Decision on Mavorixafor for WHIM Syndrome

    European Commission CHMP Opinion Norgine Mavorixafor WHIM Syndrome
  • PRESS RELEASE

    published on 02/27/2026 at 13:05, 2 months 2 days ago

    Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome

    Norgine's mavorixafor receives positive CHMP opinion for WHIM syndrome treatment in the EU. Final EC decision expected in Q2 2026. Partnership with X4 Pharmaceuticals
    CHMP Opinion Norgine Mavorixafor WHIM Syndrome X4 Pharmaceuticals
    Logo of Norgine
Accesswire
  • Published on 05/01/2026 at 18:00, 2 hours 24 minutes ago

    Star Copper to Present at the Emerging Growth Conference on May 7, 2026

  • Published on 05/01/2026 at 15:35, 4 hours 49 minutes ago

    LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement

  • Published on 05/01/2026 at 14:00, 6 hours 24 minutes ago

    CCL Industries Closing of ALT Technologies Acquisition

  • Published on 05/01/2026 at 14:00, 6 hours 24 minutes ago

    Datavault AI and CyberCatch Announce Signing of Binding Letter of Intent for Datavault AI to Acquire CyberCatch to Accelerate AI-Driven, Quantum-Resistant Cyber Risk Mitigation Solutions

  • Published on 05/01/2026 at 13:01, 7 hours 23 minutes ago

    BeMetals Announces Resumption of Trading on TSX Venture Exchange and Effective Date of Share Consolidation

View all ACCESSWIRE
EQS Group
  • Published on 05/01/2026 at 19:23, 1 hour 1 minute ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/01/2026 at 18:40, 1 hour 44 minutes ago

    Holding(s) in Company

  • Published on 05/01/2026 at 17:47, 2 hours 37 minutes ago

    Key Figures 30.04.2026

  • Published on 05/01/2026 at 17:45, 2 hours 39 minutes ago

    Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)

  • Published on 05/01/2026 at 17:21, 3 hours 3 minutes ago

    Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS
Les Echos
  • Published on 04/30/2026 at 20:00, 1 day ago

    AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue

  • Published on 04/30/2026 at 19:16, 1 day 1 hour ago

    AXA announces the results of its Shareholders' Meeting

  • Published on 04/30/2026 at 19:00, 1 day 1 hour ago

    Capital increase through exercise of subscription rights

  • Published on 04/30/2026 at 18:10, 1 day 2 hours ago

    Minutes of the Combined General Meeting held on April 30, 2026

  • Published on 04/30/2026 at 18:00, 1 day 2 hours ago

    TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy